Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat exploratory metabolic study in anemia with non-dialysis chronic kidney disease and type 2 diabetes
jRCTs041210143Completed
- Sponsor
- NPO HEART
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vadadustat in anemia of renal disease, sponsored by NPO HEART. Primary endpoint: Change in HbA1c from baseline to 24 weeks follow-up. Started Oct 2022; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCTs041210143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210143.